StockNews.com assumed coverage on shares of Lifeway Foods (NASDAQ:LWAY - Free Report) in a research report sent to investors on Tuesday morning. The firm issued a hold rating on the stock.
Lifeway Foods Stock Down 0.4 %
Shares of Lifeway Foods stock traded down $0.08 during midday trading on Tuesday, hitting $22.21. The company's stock had a trading volume of 21,611 shares, compared to its average volume of 49,924. The firm has a market capitalization of $329.15 million, a P/E ratio of 25.83 and a beta of 1.01. The stock has a 50-day simple moving average of $22.98 and a 200-day simple moving average of $22.83. Lifeway Foods has a 1-year low of $9.93 and a 1-year high of $28.61.
Insider Activity at Lifeway Foods
In other Lifeway Foods news, major shareholder Ludmila Smolyansky sold 45,000 shares of the business's stock in a transaction dated Monday, January 6th. The stock was sold at an average price of $23.49, for a total value of $1,057,050.00. Following the completion of the sale, the insider now owns 1,025,549 shares of the company's stock, valued at $24,090,146.01. The trade was a 4.20 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Over the last 90 days, insiders sold 122,034 shares of company stock valued at $2,797,217. Insiders own 18.86% of the company's stock.
Institutional Trading of Lifeway Foods
A number of institutional investors and hedge funds have recently made changes to their positions in the stock. Algert Global LLC lifted its position in shares of Lifeway Foods by 8.1% in the fourth quarter. Algert Global LLC now owns 9,076 shares of the company's stock worth $225,000 after buying an additional 680 shares during the last quarter. Barclays PLC lifted its position in shares of Lifeway Foods by 11.0% in the fourth quarter. Barclays PLC now owns 7,127 shares of the company's stock worth $176,000 after buying an additional 707 shares during the last quarter. Wells Fargo & Company MN increased its stake in shares of Lifeway Foods by 33.6% in the fourth quarter. Wells Fargo & Company MN now owns 2,855 shares of the company's stock worth $71,000 after purchasing an additional 718 shares during the period. Bank of New York Mellon Corp increased its stake in shares of Lifeway Foods by 1.6% in the fourth quarter. Bank of New York Mellon Corp now owns 55,841 shares of the company's stock worth $1,385,000 after purchasing an additional 868 shares during the period. Finally, Gamco Investors INC. ET AL increased its stake in shares of Lifeway Foods by 0.9% in the fourth quarter. Gamco Investors INC. ET AL now owns 120,350 shares of the company's stock worth $2,985,000 after purchasing an additional 1,050 shares during the period. Institutional investors and hedge funds own 36.39% of the company's stock.
Lifeway Foods Company Profile
(
Get Free Report)
Lifeway Foods, Inc produces and markets probiotic-based products in the United States and internationally. Its primary product is drinkable kefir, a cultured dairy product in various organic and non-organic sizes, flavors, and types. The company offers European-style soft cheeses; cream and other products; ProBugs, a line of kefir products designed for children; drinkable yogurt; and fresh made butter and sour cream.
Recommended Stories
Before you consider Lifeway Foods, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lifeway Foods wasn't on the list.
While Lifeway Foods currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.